Case presentation by Shrujal Baxi MD, Chief Resident
Welcome to the monthly posting of our NYU Department of Medicine’s Clinical Pathology Conference. Use the links below to review the case and the radiological findings. …
Clinical Correlations
The NYU Langone Health Online Journal of Medicine
ShortCuts-This Week in the Journals
November 5, 2007
Commentary by Henry Tran, MD
Hip fractures in the elderly are associated with a very high morbidity and mortality. Often a fracture can be the prelude to an accelerated decline in the health and functionality …
Grand Rounds: “Towards Biologically Rational Therapy for Myelodysplastic Sydrome.”
November 2, 2007
Welcome to our new Grand Rounds Series. Each week, we plan to post a summary of the week’s Medicine Grand Rounds lecture. The summaries are reviewed and approved by the grand rounds …
Elevated Total Protein and the Interpretation of Serum Protein Electrophoresis
November 1, 2007Commentary by Jamie Hoffman, MD
A healthy 54 year old man without past medical history presents for a routine physical exam for his insurance company. His blood work reveals a total protein (TP) of 9.4 g/dl and an albumin of 3.0 g/dl. What should be included in this patient’s diagnostic workup?
Targeting Triglycerides
October 31, 2007
Commentary by Josh Remick MD, PGY-3
Hypertriglyceridemia is defined by the NCEP guidelines for treatment as a fasting triglyceride level greater than 200 mg/dL after the target LDL-C level has been achieved (1). When triglyceride levels …
ShortCuts-This Week in the Journals
October 29, 2007
Commentary by Michael Poles MD, Associate Editor, Clinical Correlations
This week seems like a continuation of last week in a couple of ways. Last week our Editor-In-Chief, Dr. Neil Shapiro, wrote about the …
Inpatient Diabetes Management: Case 5
October 25, 2007
Commentary by Mary Vouyiouklis MD, Fellow, and Ann Danoff MD, Director, Division of Endocrinology, Diabetes and Metabolism, NYU Medical Center
Welcome to Case 5 of our special diabetes series intended to highlight the essentials of …
FDA Approves Label Revision for Erectile Dysfunction Drugs
October 24, 2007
Commentary by Kathy Lee, Pharm.D. Pharmacy Practice Resident
On October 18 2007, the FDA announced the approval of labeling changes to erectile dysfunction (ED) drugs in the class known as phosphodiesterase type 5 (PDE-5) inhibitors. …